First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer's Disease Six Month Interim Results Expected in 1H 2026 Topline Results Anticipated by end of 2026 CAMBRIDGE, Massachusetts ...

The company said the discontinuation was due to several reasons,” Reuters news service reported, “including limited interest in gene therapies for the bleeding disorder.” (Pfizer had earlier dumped a ...

U.S.-based Lankry brings over 20 years of financial leadership in biotech and healthcare with a proven track record of ...

A recent discovery could change how we administer vaccines. Researchers have observed that the choice of arm for injections ...

PFAS are found in multiple everyday products, such as cosmetics, outdoor clothing and coated pans. This is because of their ...

The study found that the location of the booster shot matters. Specifically, when the booster is given in the same arm as the ...

Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

If you've been hopping between arms for booster shots, a new study suggests that your lymph nodes remember exactly where you ...

During a live event, Krish Patel, MD, surveyed participants on using bispecific T-cell engagers vs loncastuximab in a patient ...

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

Oklahoma scientists find interferon-beta may help MS patients on B cell therapy fight infections like flu and Covid-19, new ...